DePuy Tagged Articles

Judge moves second DePuy hip bellwether trial to September

Posted: May 10, 2013 Pharmaceutical

A federal judge overseeing multidistrict litigation (MDL) involving all-metal ASR hip implants made by DePuy Orthopedics has moved the second bellwether trial from June to September.

DePuy seeks to overturn $8.26 million jury award in first ASR hip trial

Posted: May 9, 2013 Pharmaceutical

Johnson & Johnson and its orthopedics unit DePuy seek to overturn a Los Angeles jury’s decision to award $8.26 million to a plaintiff for injuries he received from a metal-on-metal DePuy ASR hip implant. The companies claim that the jury’s

Designer of metal hip implant says he no longer uses the defective devices

Posted: April 4, 2013 Pharmaceutical

Dr. Thomas Schmalzried, an orthopedic surgeon and one of the lead designers of the ASR metal-on-metal hip replacement system made by Johnson & Johnson subsidiary DePuy Orthopaedics, testified before a jury this week that he would not implant the device

DePuy’s ASR hip implant caused plaintiff’s bone decay, surgeon tells jury

Posted: April 1, 2013 Pharmaceutical

An orthopedic surgeon testifying on behalf of a woman who alleges she was injured by ASR metal hip implants manufactured by DePuy Orthopedics told jurors in the Circuit Court of Cook County, Illinois, that metal debris from the hip devices

Johnson & Johnson ordered to pay $8.3 million in first hip implant lawsuit to go to trial

Posted: March 8, 2013 Pharmaceutical

A Los Angeles jury found in favor of Plaintiff Loren “Bill” Kransky, ordering Johnson & Johnson to pay the man $8.3 million in compensatory damages for debilitating injuries he suffered as a result of a faulty hip implant. This was

Hip implant failure 29 percent higher in women, new study finds

Posted: February 23, 2013 Pharmaceutical

A new study of more than 35,100 patients who were surgically implanted with artificial hip devices reveals that women are much more likely than men to require revision surgery within the first three years to correct problems with the implant.

Hip implant failures more likely in women than men

Posted: February 21, 2013 Pharmaceutical

Women are more likely to need revision surgery to remove and replace their artificial hips than men, according to a study published in JAMA Internal Medicine.

Daughter testifies that DePuy hip implant ruined her father’s health

Posted: February 16, 2013 Pharmaceutical

The daughter of the first plaintiff to have his case against DePuy Orthopedics over its faulty ASR hip implants go to trial testified in court Monday, giving an emotional account of witnessing her father’s health decline after he was implanted

Emails presented in DePuy trial show marketer’s concerns over ASR hip implant safety

Posted: February 14, 2013 Pharmaceutical

Internal communications among DePuy executives discussing how to handle metal-on-metal ASR hip problems were presented to jurors hearing the first of several thousand personal-injury lawsuits involving the faulty devices to go to trial. DePuy is a subsidiary of Johnson &

Testimony in first DePuy trial indicates company failed to act on ASR hip warnings

Posted: February 12, 2013 Pharmaceutical

Court documents and the recent testimony given by DePuy officials during the first ASR metal hip case to go to trial indicate the company took very little action, if any, to warn prospective patients about the serious risks its all-metal